Dynamics of platelet ultrastructural changes under correction of arterial blood pressure with losartan in patients with diabetes mellitus in a subcompensation

We have conducted a quantitative evaluation of ultrastructural changes in the dynamics of platelets in the patients with diabetes mellitus type 2 in a subcompensation phase with arterial hypertension under correction of arterial blood pres-sure with losartan and with considering of microalbuminuria....

Full description

Bibliographic Details
Main Author: Pertseva N.O.
Format: Article
Language:Russian
Published: Ministry of Health of Ukraine. Dnipropetrovsk Medical Academy 2012-01-01
Series:Морфологія
Subjects:
Online Access:http://www.morphology.dp.ua/_pub/MORPHO-2012-06-03/12pnotfs.pdf
id doaj-ea7f29e7438f4a1394864ee5e4e9f2b1
record_format Article
spelling doaj-ea7f29e7438f4a1394864ee5e4e9f2b12020-11-24T22:48:20ZrusMinistry of Health of Ukraine. Dnipropetrovsk Medical Academy Морфологія1997-96652012-01-01634350Dynamics of platelet ultrastructural changes under correction of arterial blood pressure with losartan in patients with diabetes mellitus in a subcompensationPertseva N.O.We have conducted a quantitative evaluation of ultrastructural changes in the dynamics of platelets in the patients with diabetes mellitus type 2 in a subcompensation phase with arterial hypertension under correction of arterial blood pres-sure with losartan and with considering of microalbuminuria. Itis shown that in the patients without the renal complications observed a damage of thrombocyte hemostasis, as a result of this is a significant increase in the relative amount of activated platelets with rising of content degranulated forms with an imbalance of granules and reduction of the mitochondrial apparatus. Inclusion of losartan in the treatment makes it possible to reduce the degree of ultrastructural disorders of platelets from the 6th month of the treatment. In the patients with microalbuminuria showed a strong damage of thrombocyte hemostasis due to significant growth in the content ofthe activated, degranulated and aggregated forms of platelets and development of hyperactivation of platelets by hyaline type. The standard treatment for one year is accompanied by increasing imbalance of granulomer of most platelets and the degree of the heteromorphic pool with a highercontent of degranulated and aggregated forms. Losartan usage limits the enlargement of ultrastructural disorders and leads to significant reduction of platelet degranulation.http://www.morphology.dp.ua/_pub/MORPHO-2012-06-03/12pnotfs.pdfdiabetes mellitus type 2subcompensationarterial hypertensionplatelets ultrastructurelosartan
collection DOAJ
language Russian
format Article
sources DOAJ
author Pertseva N.O.
spellingShingle Pertseva N.O.
Dynamics of platelet ultrastructural changes under correction of arterial blood pressure with losartan in patients with diabetes mellitus in a subcompensation
Морфологія
diabetes mellitus type 2
subcompensation
arterial hypertension
platelets ultrastructure
losartan
author_facet Pertseva N.O.
author_sort Pertseva N.O.
title Dynamics of platelet ultrastructural changes under correction of arterial blood pressure with losartan in patients with diabetes mellitus in a subcompensation
title_short Dynamics of platelet ultrastructural changes under correction of arterial blood pressure with losartan in patients with diabetes mellitus in a subcompensation
title_full Dynamics of platelet ultrastructural changes under correction of arterial blood pressure with losartan in patients with diabetes mellitus in a subcompensation
title_fullStr Dynamics of platelet ultrastructural changes under correction of arterial blood pressure with losartan in patients with diabetes mellitus in a subcompensation
title_full_unstemmed Dynamics of platelet ultrastructural changes under correction of arterial blood pressure with losartan in patients with diabetes mellitus in a subcompensation
title_sort dynamics of platelet ultrastructural changes under correction of arterial blood pressure with losartan in patients with diabetes mellitus in a subcompensation
publisher Ministry of Health of Ukraine. Dnipropetrovsk Medical Academy
series Морфологія
issn 1997-9665
publishDate 2012-01-01
description We have conducted a quantitative evaluation of ultrastructural changes in the dynamics of platelets in the patients with diabetes mellitus type 2 in a subcompensation phase with arterial hypertension under correction of arterial blood pres-sure with losartan and with considering of microalbuminuria. Itis shown that in the patients without the renal complications observed a damage of thrombocyte hemostasis, as a result of this is a significant increase in the relative amount of activated platelets with rising of content degranulated forms with an imbalance of granules and reduction of the mitochondrial apparatus. Inclusion of losartan in the treatment makes it possible to reduce the degree of ultrastructural disorders of platelets from the 6th month of the treatment. In the patients with microalbuminuria showed a strong damage of thrombocyte hemostasis due to significant growth in the content ofthe activated, degranulated and aggregated forms of platelets and development of hyperactivation of platelets by hyaline type. The standard treatment for one year is accompanied by increasing imbalance of granulomer of most platelets and the degree of the heteromorphic pool with a highercontent of degranulated and aggregated forms. Losartan usage limits the enlargement of ultrastructural disorders and leads to significant reduction of platelet degranulation.
topic diabetes mellitus type 2
subcompensation
arterial hypertension
platelets ultrastructure
losartan
url http://www.morphology.dp.ua/_pub/MORPHO-2012-06-03/12pnotfs.pdf
work_keys_str_mv AT pertsevano dynamicsofplateletultrastructuralchangesundercorrectionofarterialbloodpressurewithlosartaninpatientswithdiabetesmellitusinasubcompensation
_version_ 1725678598504841216